This may be a relatively minor concern for certain solid tumors but is a major problem for all blood cancers and some solid tumors. A critical aspect of the BMT program at Johns Hopkins is the Graft Engineering Laboratory. This laboratory processes all stem cell products for transplantation, and is a world-renowned leader in innovative approaches for improving the safety and efficacy of stem cell products. The nursing staff is highly trained in the care of BMT patients and in critical care. The units are capable of providing conventional and intensive care.
All rooms are private with special air-filtering to decrease the risk of infections.
Some patients undergoing BMT now receive their transplants as outpatients in our new IPOP unit. Click here for information about outpatient transplantation in our new IPOP unit. BMT Faculty Dr. Richard Jones is the director of the Bone Marrow Transplant Unit. Dr. Jones also sees patients in The Myeloid Disorders Clinic. Dr. Michael Grever is Director of the Division of Hematologic Malignancies .